Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133395) titled 'The Effect of Enhanced Intravenous Insulin Therapy on the Prognosis of Patients with Sepsis and a High Stress-Hyperglycemia Ratio' on Sept. 24.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Wuxi people's Hospital
Condition:
stress-induced high blood sugar
Intervention:
Insulin treatment group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-01
Target Sample Size: Insulin treatment group:162;Control Group:162;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=338704
Published by HT Digita...